Longview Acquisition II Debt to Equity Ratio 2021-2022 | LGV

Current and historical debt to equity ratio values for Longview Acquisition II (LGV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Longview Acquisition II debt/equity for the three months ending September 30, 2022 was 0.00.
Longview Acquisition II Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-09-30 $0.73B $-0.03B -21.96
2022-06-30 $0.73B $-0.03B -21.31
2022-03-31 $0.73B $-0.04B -17.71
2021-12-31 $0.74B $-0.05B -16.14
2021-09-30 $0.75B $-0.06B -13.46
2021-06-30 $0.75B $-0.06B -12.31
2021-03-31 $0.76B $-0.07B -11.69
2020-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.000B $0.000B
Longview Acquisition Corp. II entered into a definitive business combination agreement with HeartFlow Holding Inc.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.781B 26.81
Intuitive Surgical (ISRG) United States $217.430B 113.68
Alcon (ALC) Switzerland $43.790B 29.30
Edwards Lifesciences (EW) United States $40.720B 25.86
IQVIA Holdings (IQV) United States $37.284B 20.54
IDEXX Laboratories (IDXX) United States $35.259B 41.52
DexCom (DXCM) United States $34.017B 51.23
Waters (WAT) United States $24.246B 35.85
STERIS (STE) Ireland $21.575B 24.84
SONOVA HOLDING (SONVY) Switzerland $20.893B 0.00
Hologic (HOLX) United States $16.069B 17.45
Fresenius Medical Care AG KGaA (FMS) Germany $13.597B 13.96
Globus Medical (GMED) United States $12.707B 32.18
Sysmex ADR (SSMXY) Japan $11.852B 37.16
Penumbra (PEN) United States $10.587B 103.70
Masimo (MASI) United States $9.271B 44.86
Glaukos (GKOS) United States $8.829B 0.00
Teleflex (TFX) United States $8.395B 13.39
Integer Holdings (ITGR) United States $4.744B 26.89
Inari Medical (NARI) United States $4.650B 0.00
PROCEPT BioRobotics (PRCT) United States $3.570B 0.00
Veracyte (VCYT) United States $3.336B 100.12
LivaNova (LIVN) United Kingdom $2.642B 15.25
Nihon Kohden (NHNKY) Japan $2.325B 17.66
Tandem Diabetes Care (TNDM) United States $2.299B 0.00
Elekta AB (EKTAY) Sweden $2.235B 20.10
TransMedics (TMDX) United States $2.080B 65.93
Integra LifeSciences Holdings (IART) United States $1.918B 10.02
Alphatec Holdings (ATEC) United States $1.614B 0.00
Artivion (AORT) United States $1.290B 85.50
RxSight (RXST) United States $1.286B 0.00
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.979B 0.00
AxoGen (AXGN) United States $0.831B 0.00
Mesa Laboratories (MLAB) United States $0.787B 18.55
IRadimed (IRMD) United States $0.752B 40.63
AVANOS MEDICAL, INC (AVNS) United States $0.729B 12.39
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
SiBone (SIBN) United States $0.698B 0.00
OrthoPediatrics (KIDS) United States $0.657B 0.00
Treace Medical Concepts (TMCI) United States $0.587B 0.00
Semler Scientific (SMLR) United States $0.576B 30.30
Pacific Biosciences Of California (PACB) United States $0.496B 0.00
ClearPoint Neuro (CLPT) United States $0.494B 0.00
AngioDynamics (ANGO) United States $0.488B 0.00
Delcath Systems (DCTH) United States $0.486B 0.00
NeuroPace (NPCE) United States $0.419B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.417B 22.57
Alpha Tau Medical (DRTS) Israel $0.279B 0.00
Inogen (INGN) United States $0.258B 0.00
Accuray (ARAY) United States $0.229B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.115B 12.26
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
908 Devices (MASS) United States $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.076B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Neuronetics (STIM) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Rapid Micro Biosystems (RPID) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
Lucid Diagnostics (LUCD) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00